Pages that link to "Q42802122"
Jump to navigation
Jump to search
The following pages link to The mechanism of insulin resistance caused by HIV protease inhibitor therapy. (Q42802122):
Displaying 50 items.
- Metformin: new understandings, new uses (Q22241434) (← links)
- The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications (Q24598812) (← links)
- Effect of rosiglitazone and metformin on insulin resistance in patients infected with human immunodeficiency virus receiving highly active antiretroviral therapy containing protease inhibitor: randomized prospective controlled clinical trial (Q24645513) (← links)
- The blind men 'see' the elephant-the many faces of fatty liver disease (Q24654991) (← links)
- Metformin: Current knowledge (Q26853666) (← links)
- Novel therapeutic targets of tumor metabolism (Q27005930) (← links)
- HIV infection and cardiovascular disease (Q27008915) (← links)
- HIV protease inhibitors: a review of molecular selectivity and toxicity (Q28082749) (← links)
- Clinical review#: Lipodystrophies: genetic and acquired body fat disorders (Q28246346) (← links)
- GLUT4 translocation precedes the stimulation of glucose uptake by insulin in muscle cells: potential activation of GLUT4 via p38 mitogen-activated protein kinase (Q28362404) (← links)
- Metabolic effects of indinavir in healthy HIV-seronegative men (Q28366603) (← links)
- HIV protease inhibitors act as competitive inhibitors of the cytoplasmic glucose binding site of GLUTs with differing affinities for GLUT1 and GLUT4 (Q28477208) (← links)
- HIV-protease inhibitors induce expression of suppressor of cytokine signaling-1 in insulin-sensitive tissues and promote insulin resistance and type 2 diabetes mellitus (Q28582686) (← links)
- HIV and its relationship to insulin resistance and lipid abnormalities. (Q30239101) (← links)
- Ageing and inflammation in patients with HIV infection. (Q30244296) (← links)
- Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy (Q30248286) (← links)
- WZB117 (2-Fluoro-6-(m-hydroxybenzoyloxy) Phenyl m-Hydroxybenzoate) Inhibits GLUT1-mediated Sugar Transport by Binding Reversibly at the Exofacial Sugar Binding Site (Q30395148) (← links)
- Reduced adipogenic gene expression in thigh adipose tissue precedes human immunodeficiency virus-associated lipoatrophy (Q30481446) (← links)
- Creatine fails to augment the benefits from resistance training in patients with HIV infection: a randomized, double-blind, placebo-controlled study (Q33412387) (← links)
- Purification and characterization of mammalian glucose transporters expressed in Pichia pastoris (Q33664015) (← links)
- Isoform-selective inhibition of facilitative glucose transporters: elucidation of the molecular mechanism of HIV protease inhibitor binding. (Q33718467) (← links)
- Severe weight gain, lipodystrophy, dyslipidemia, and obstructive sleep apnea in a human immunodeficiency virus-infected patient following highly active antiretroviral therapy (Q33722450) (← links)
- HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters (Q33729269) (← links)
- High correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Côte d'Ivoire (Q33764308) (← links)
- Severe impairment of endothelial function with the HIV-1 protease inhibitor indinavir is not mediated by insulin resistance in healthy subjects (Q33816114) (← links)
- Long-term ritonavir exposure increases fatty acid and glycerol recycling in 3T3-L1 adipocytes as compensatory mechanisms for increased triacylglycerol hydrolysis (Q33848305) (← links)
- The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms (Q33889580) (← links)
- Effects of switching from lopinavir/ritonavir to atazanavir/ritonavir on muscle glucose uptake and visceral fat in HIV-infected patients (Q33918414) (← links)
- The SLC2 (GLUT) family of membrane transporters (Q33926133) (← links)
- Disorders of glucose metabolism in patients infected with human immunodeficiency virus (Q34092346) (← links)
- Adverse metabolic consequences of HIV protease inhibitor therapy: the search for a central mechanism (Q34187120) (← links)
- Saquinavir soft gelatin capsule: a comparative safety review (Q34248421) (← links)
- Effects of the HIV protease inhibitor ritonavir on GLUT4 knock-out mice (Q34299021) (← links)
- Metabolic complications associated with antiretroviral therapy (Q34305866) (← links)
- Effects of the human immunodeficiency virus-protease inhibitor, ritonavir, on basal and catecholamine-stimulated lipolysis (Q34312147) (← links)
- Direct comparison of the acute in vivo effects of HIV protease inhibitors on peripheral glucose disposal (Q34333596) (← links)
- A structural basis for the acute effects of HIV protease inhibitors on GLUT4 intrinsic activity. (Q34455618) (← links)
- HIV protease inhibitors acutely impair glucose-stimulated insulin release. (Q34455624) (← links)
- Sterol regulatory element-binding proteins and reactive oxygen species: potential role in highly-active antiretroviral therapy (HAART)-associated lipodystrophy (Q34460031) (← links)
- Strategies for treating HIV-related lipodystrophy (Q34481623) (← links)
- Human Cytomegalovirus Activates Glucose Transporter 4 Expression To Increase Glucose Uptake during Infection (Q34529843) (← links)
- Pathogenesis of HIV-associated cardiovascular complications (Q34547836) (← links)
- Differential subcutaneous adipose tissue gene expression patterns in a randomized clinical trial of efavirenz or lopinavir-ritonavir in antiretroviral-naive patients. (Q34596899) (← links)
- Protease inhibitors and decreased birth weight in HIV-infected pregnant women with impaired glucose tolerance. (Q34705263) (← links)
- Acute toxicity of second generation HIV protease-inhibitors in combination with radiotherapy: a retrospective case series (Q34722581) (← links)
- GS-8374, a novel HIV protease inhibitor, does not alter glucose homeostasis in cultured adipocytes or in a healthy-rodent model system. (Q34737804) (← links)
- ATM and GLUT1-S490 phosphorylation regulate GLUT1 mediated transport in skeletal muscle (Q34776170) (← links)
- HIV protease inhibitors and obesity (Q34792983) (← links)
- Effects of HIV protease inhibitor therapy on lipid metabolism (Q35053466) (← links)
- Insulin resistance in HIV-related lipodystrophy (Q35087005) (← links)